Allergen immunotherapy on the way to product-based evaluation—a WAO statement

Allergen immunotherapy (AIT) is widely used in clinical practice for patients with moderate to severe allergic rhinitis due to inhalant allergens and may be delivered via subcutaneous (SCIT) and sublingual routes (SLIT). However, the quality of evidence for individual AIT products is very heterogene...

Full description

Saved in:

Bibliographic Details
Published in:	The World Allergy Organization journal Vol. 8; no. 1; pp. 29 - 4
Main Authors:	Bachert, Claus, Larché, Mark, Bonini, Sergio, Canonica, Giorgio Walter, Kündig, Thomas, Larenas-Linnemann, Desiree, Ledford, Dennis, Neffen, Hugo, Pawankar, Ruby, Passalacqua, Giovanni
Format:	Journal Article
Language:	English
Published:	London Elsevier Inc 2015 Elsevier BV BioMed Central BioMed Central Ltd Elsevier
Subjects:	Allergens Allergies Allergology Analysis Asthma Care and treatment EUROPE Evidence-based medicine Health aspects Immunologic diseases. Allergy Immunology Immunology and Allergy Immunotherapy Medical colleges Medicine Medicine & Public Health Medicine and Health Sciences ORGANIZATION Position and Guidelines Position Article and Guidelines RANDOMIZED CONTROLLED-TRIAL RC581-607 RECOMMENDATIONS RHINOCONJUNCTIVITIS STANDARDIZATION Allergic Rhinitis Individual Product Allergen Immunotherapy Allergen Extract Inhalant Allergen
ISSN:	1939-4551, 1939-4551
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!